Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by ganja50on Jul 22, 2015 5:57pm

217 Views

Post# 23950581

RE:RE:Cure For Cancer Worth $50 Trillion, Study Says

"If TLT's human trials are successful, IMO TLT will have to be worth somewhere north of $10 Billion. However I'd prefer they only sell a max of 50% and used that revenue for a substantial one time dividend and the balance to open clinics with a big pharma partner, around the country(& world), to cure patients. @ $50K per,"

Great post, great idea sky1

Bullboard Posts

Southern Ontario mineral processing operation receives green fund support